Cellular Therapies for Neurological Injury has been published!
Dr. Charles Cox is the editor of Cellular Therapy for Neurological Injury which discusses the current status of cellular therapy for neurological disorders. The primary areas of focus include traumatic brain injury, stroke (ischemic and hemorrhagic), and spinal cord injury. The…
March of Dimes 2016 Walk
Once again, it is time for the March of Dimes Walk for Babies. The Department of Pediatric Surgery is organizing a team for the walk and we are asking you to walk with us. The walk will be April 24th…
Memorial Hermann-Texas Medical Center and Children’s Memorial Hermann Hospital Announce 2015 Physicians of the Year
Memorial Hermann-Texas Medical Center (TMC) and Children’s Memorial Hermann Hospital are proud to announce the two individuals selected as their 2015 Physicians of the Year: Saleem Khan, M.D., Chief of Emergency General Surgery at McGovern Medical School at UTHealth, affiliated with Memorial…
Distinguished Physicians honored at annual meeting
Memorial Hermann-Texas Medical Center (TMC) honored three McGovern Medical School faculty members with the Distinguished Physician Award at the Annual Medical Staff Meeting held in December. Recognized for their significant contributions while spending the majority of their career at Memorial…
Many Faces of UTHealth: Cox discusses growth in pediatrics
For Charles S. Cox, Jr., M.D., the initial appeal of spending his career at UTHealth was the location – Houston is his hometown – but the great community is what keeps him here. “Other positions don’t combine the clinical excellence,…
Propranolol and Mesenchymal Stromal Cells Combine to Treat TBI
Review of “Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury” from Stem Cells Translational Medicine by Stuart P. Atkinson While the initial consequences of a traumatic brain injury (TBI) are devastating enough, survivors face varying physical, cognitive,…
Immatics and UTHealth to collaborate on cellular manufacturing for Phase 1 clinical trials
Newswise — HOUSTON – (Oct. 16, 2015) – Immatics US, Inc., a subsidiary of Immatics Biotechnologies GmbH, and The University of Texas Health Science Center at Houston (UTHealth) will collaborate on cellular manufacturing for adoptive cellular therapy (ACT) clinical trials….
The Inside Scoop: A medical mission hits close to home
This past December, I had the opportunity to accompany a pediatric neurosurgery team from Children’s Memorial Hermann Hospital and Mischer Neuroscience Institute to Port au Prince, Haiti. During the five-day trip, our team performed an incredible 25 surgeries. As a…
John’s Story: Parents stop at nothing to find cure for son
When you love someone so much, giving up is not an option. Ed and Maurie Drambel didn’t set out to be trailblazers but John, their 11-year-old son, lit a fire in them…a fire stoked by those who said there’s no…
Children’s Memorial Hermann Hospital officially designated a Baby-Friendly® Hospital!
Children’s Memorial Hermann Hospital has been officially designated a Baby-Friendly Hospital! It’s official! Based on the results of data collected during the rigorous onsite assessment survey and the final review of the External Review Board, Baby-Friendly USA determined that Children’s…